Phase II Trial of High-Dose Radiotherapy vs. Low-Dose Radiation, Demonstrating Low-Dose Mediated Immune-Cell Infiltration.

K He,R R Patel, H B Barsoumian, J Y Chang, C Tang, N I Comeaux,M S Ning,S Gandhi,M Davies, I Glitza, D S Hong,J Heymach,Q N Nguyen,A Diab, S G Chun,P Lee, G R Blumenschein, F V Fossella,D Chen, J W Welsh

International journal of radiation oncology, biology, physics（2021）

引用 2|浏览6

暂无评分

摘要

Low-dose RT is an effective and safe way to enhance individual lesion-specific response rates among progressing patients with solid tumors, with the ability to improve the infiltration of effector immune cells into the tumor microenvironment.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要